Sign in
Not yet recruitingPhase 1/2

The Effect of Preoperative Duloxetine on the Occurance of Postoperative Delirium in Patients Undergoing Cancer Surgery.

Key facts

Who runs it
Amira Hassan Ahmed Ali
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
Phase
Phase 1/2
People taking part
42 people, planned
Started
Aug 2023
Expected to end
Dec 2026
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Duloxetine 60 MG
Record updated
17 July 2023

Who can take part

Age
20 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • All patients will sign an informed consent prior to inclusion in the study
  • Adult patients with ASA class I-III, undergoing cancer surgery

Who cannot take part

  • Documented signs of dementia after psychiatric evaluations
  • Psychosis stroke, meningitis, or brain tumors
  • Patients with pre-existing neuro- cognitive dysfunction
  • Language barriers or deafness

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 20 and 80 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is prospective double-blinded placebo-randomized controlled trial that aims to compare the effect of preoperative administration of oral duloxetine 60 mg on decreasing the incidence of postoperative delirium in cancer patients undergoing surgery.

The 2 groups in the trial

  • Duloxetine group (Group D)Treatment being tested

    patients received oral duloxetine 60 mg 2 hours just before operation.

    Treatment: Duloxetine 60 MG

  • Control group (Group C)Placebo, for comparison

    patients received an identical placebo pill 2 hours just before operation.

    Treatment: Duloxetine 60 MG

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effect of Preoperative Duloxetine on the Occurance of Postoperative Delirium in Patients Undergoing Cancer Surgery .
Criteria questions
Built from NCT05949229, who can take part
Record updated
17 July 2023